Invention Grant
- Patent Title: Substituted heterocyclic amides
- Patent Title (中): 取代的杂环酰胺
-
Application No.: US10332120Application Date: 2001-07-18
-
Publication No.: US07160878B2Publication Date: 2007-01-09
- Inventor: David Kent Herron , Sajan Joseph , Angela Lynn Marquart , John Joseph Masters , David Mendel , Gerald Floyd Smith , Philip Parker Waid , Michael Robert Wiley , Ying Kwong Yee
- Applicant: David Kent Herron , Sajan Joseph , Angela Lynn Marquart , John Joseph Masters , David Mendel , Gerald Floyd Smith , Philip Parker Waid , Michael Robert Wiley , Ying Kwong Yee
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Thomas E Jackson
- International Application: PCT/US01/16528 WO 20010718
- International Announcement: WO02/10154 WO 20020207
- Main IPC: A61P7/02
- IPC: A61P7/02 ; A61K31/55 ; C07D243/08
Abstract:
This application relates to a compound of formula (I) (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.
Public/Granted literature
- US20040097491A1 Substituted heterocyclic amides Public/Granted day:2004-05-20
Information query
